Intervention Review

Adrenaline (epinephrine) for the treatment of anaphylaxis with and without shock

  1. Aziz Sheikh1,*,
  2. Yasser A Shehata2,
  3. Simon GA Brown3,
  4. F Estelle R Simons4

Editorial Group: Cochrane Anaesthesia Group

Published Online: 8 OCT 2008

Assessed as up-to-date: 30 NOV 2010

DOI: 10.1002/14651858.CD006312.pub2


How to Cite

Sheikh A, Shehata YA, Brown SGA, Simons FER. Adrenaline (epinephrine) for the treatment of anaphylaxis with and without shock. Cochrane Database of Systematic Reviews 2008, Issue 4. Art. No.: CD006312. DOI: 10.1002/14651858.CD006312.pub2.

Author Information

  1. 1

    The University of Edinburgh, Centre for Population Health Sciences, Edinburgh, UK

  2. 2

    The University of Edinburgh, Division of Community Health Sciences: GP section, Edinburgh, UK

  3. 3

    The University of Western Australia at Fremantle Hospital, Department of Emergency Medicine, Fremantle, Western Australia, Australia

  4. 4

    Faculty of Medicine, University of Manitoba, Department of Pediatrics & Child Health; Department of Immunology, Winnipeg, MB, Canada

*Aziz Sheikh, Centre for Population Health Sciences, The University of Edinburgh, Medical School, Doorway 3, Teviot Place, Edinburgh, EH8 9AG, UK. Aziz.Sheikh@ed.ac.uk. asheikh2@partners.org.

Publication History

  1. Publication Status: Stable (no update expected for reasons given in 'What's new')
  2. Published Online: 8 OCT 2008

SEARCH

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Flavio G. Gaudio, Jay Lemery, David E. Johnson, Wilderness Medical Society Practice Guidelines for the Use of Epinephrine in Outdoor Education and Wilderness Settings: 2014 Update, Wilderness & Environmental Medicine, 2014, 25, 4, S15

    CrossRef

  2. 2
    Karen Jui Lin Choo, F Estelle R Simons, Aziz Sheikh, Glucocorticoids for the treatment of anaphylaxis, Evidence-Based Child Health: A Cochrane Review Journal, 2013, 8, 4
  3. 3
    Michael Rieder, New Ways to Detect Adverse Drug Reactions in Pediatrics, Pediatric Clinics of North America, 2012, 59, 5, 1071

    CrossRef

  4. 4
    M. Gallagher, A. Worth, S. Cunningham-Burley, A. Sheikh, Epinephrine auto-injector use in adolescents at risk of anaphylaxis: a qualitative study in Scotland, UK, Clinical & Experimental Allergy, 2011, 41, 6
  5. 5
    E. Arroabarren, E. M. Lasa, I. Olaciregui, C. Sarasqueta, J. A. Muñoz, E. G. Pérez-Yarza, Improving anaphylaxis management in a pediatric emergency department, Pediatric Allergy and Immunology, 2011, 22, 7
  6. 6
    Flavio Gaudio, Jay Lemery, David Johnson, Recommendations on the Use of Epinephrine in Outdoor Education and Wilderness Settings, Wilderness & Environmental Medicine, 2010, 21, 3, 185

    CrossRef

  7. 7
    Aziz Sheikh, F Estelle R Simons, Victoria Barbour, Allison Worth, Adrenaline auto-injectors for the treatment of anaphylaxis with and without cardiovascular collapse in the community, The Cochrane Library,
  8. 8
    Aziz Sheikh, F Estelle R Simons, Allison Worth, Adrenaline auto-injectors for the treatment of anaphylaxis with and without cardiovascular collapse in the community, The Cochrane Library,
  9. 9
    Karen Jui Lin Choo, F Estelle R Simons, Aziz Sheikh, Glucocorticoids for the treatment of anaphylaxis, The Cochrane Library,
  10. 10
    Karen Jui Lin Choo, F Estelle R Simons, Aziz Sheikh, Glucocorticoids for the treatment of anaphylaxis, The Cochrane Library,